NM_005159.5(ACTC1):c.513C>T (p.Tyr171=) AND not specified

Germline classification:: Benign/Likely benign (2 submissions)
Last evaluated:: Aug 22, 2013
Review status:: 2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000038331.7

Allele description [Variation Report for NM_005159.5(ACTC1):c.513C>T (p.Tyr171=)]

NM_005159.5(ACTC1):c.513C>T (p.Tyr171=)

Genes:

GJD2-DT:GJD2 divergent transcript [Gene - HGNC]
ACTC1:actin alpha cardiac muscle 1 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

15q14

Genomic location:

Preferred name:

NM_005159.5(ACTC1):c.513C>T (p.Tyr171=)

Other names:

p.Y171Y:TAC>TAT

HGVS:

NC_000015.10:g.34792511G>A
NG_007553.1:g.8216C>T
NM_005159.5:c.513C>TMANE SELECT
NP_005150.1:p.Tyr171=
LRG_388t1:c.513C>T
LRG_388:g.8216C>T
NC_000015.9:g.35084712G>A
NM_005159.4:c.513C>T
c.513C>T
p.Tyr171Tyr

Links:

dbSNP: rs145023222

NCBI 1000 Genomes Browser:

rs145023222

Molecular consequence:

NM_005159.5:c.513C>T - synonymous variant - [Sequence Ontology: SO:0001819]

Observations:

Condition(s)

Synonyms:: AllHighlyPenetrant
Identifiers:: MedGen: CN169374

Recent activity

Clear Turn Off Turn On

Homo sapiens decorin D mRNA, complete cds, alternatively spliced
Homo sapiens decorin D mRNA, complete cds, alternatively spliced
gi|7381210|gb|AF138303.1|

Nucleotide
lipoprotein adhesin JlpA [Campylobacter jejuni]
lipoprotein adhesin JlpA [Campylobacter jejuni]
gi|2518337832|gb|KAJ9877362.1||gnl| DJB|QR426_03325

Protein
Squalius carolitertii isolate SQCA5 rhodopsin (RHO) gene, partial cds
Squalius carolitertii isolate SQCA5 rhodopsin (RHO) gene, partial cds
gi|2427552648|gb|OP762399.1|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000062002	Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine	criteria provided, single submitter (LMM Criteria)	Likely benign (Aug 22, 2013)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]
SCV000166840	GeneDx	criteria provided, single submitter (GeneDx Variant Classification (06012015))	Benign (Nov 28, 2012)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000062002

Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine

criteria provided, single submitter

(LMM Criteria)

Likely benign
(Aug 22, 2013)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

SCV000166840

GeneDx

criteria provided, single submitter

(GeneDx Variant Classification (06012015))

Benign
(Nov 28, 2012)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	not provided	not provided	not provided	not provided	not provided	clinical testing
not provided	germline	not provided	3	3	not provided	not provided	not provided	clinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]

PMID:: 24033266
PMCID:: PMC3995020

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000062002.5

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	3	not provided	not provided	clinical testing	PubMed (1)

Description

Tyr171Tyr in exon 3 of ACTC1: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue and is not located with in the splice consensus sequence. It has been identified in 0.2% (8/4402) of Afr ican American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs145023222). Tyr171Tyr in ex on 3 of ACTC1 (rs145023222; allele frequency = 0.2%, 8/4402) **

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	not provided	not provided	not provided	not provided		3	not provided	3	not provided

From GeneDx, SCV000166840.11

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine